Impact of hormone-therapy used in CRPC patients: evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice

Martine Dubois (1) , Tareq Al Sagheer (1) , Cynthia Campart (1) , Laurence Desrues (1, 2) , Marie Lange (3, 4, 5) , Pierrick Gandolfo (1, 2) , Florence Joly (4, 5) , Hélène Castel (1, 2, 5)

1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 DC2N - Différenciation et communication neuronale et neuroendocrine
3 CRC - Centre de recherche clinique [CHU Caen]
4 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]
5 Plateforme Cancer et Cognition

Domaines: Sciences du Vivant [q-bio]; Cancer; Sciences cognitives

Martine Dubois, Tareq Al Sagheer, Cynthia Campart, Laurence Desrues, Marie Lange, et al.. Impact of hormone-therapy used in CRPC patients: evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice. NeuroFrance, May 2019, Marseille, France. ⟨hal-02335635⟩